2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide

Base Information

Chemical Name:2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide
CAS No.:1384248-84-3
Molecular Formula:C₂₁H₃₁N₅O₃
Molecular Weight:401.509
Hs Code.:

Synonyms:2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide

Suppliers and Price of 2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide

Supply Marketing:

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

Total 0 raw suppliers

Chemical Property of 2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide

Chemical Property:

Purity/Quality:

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:

Useful:

Technology Process of 2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide

There total 7 articles about 2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield: 36.0%

: 1384248-75-2
2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)acetic acid

: 108-00-9
N,N-dimethylethylenediamine

: 1384248-84-3
2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide

Guidance literature:: With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; HATU; In N,N-dimethyl-formamide; at 20 ℃;
DOI:10.1016/j.tetlet.2012.05.025

Reference yield:

: 74628-31-2
N-1-cyclohexylbenzene-1,2-diamine

: 1384248-84-3
2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide

Guidance literature:: Multi-step reaction with 5 steps

1.1: potassium carbonate / N,N-dimethyl-formamide / 7 h / 65 °C

2.1: 2,4-dichlorophenoxyacetic acid dimethylamine / 0.5 h / 150 °C / Microwave irradiation

3.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 20 °C

3.2: 16 h

4.1: palladium 10% on activated carbon; hydrogen / ethanol; ethyl acetate / 20 °C

5.1: dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; HATU / N,N-dimethyl-formamide / 20 °C

With dmap; palladium 10% on activated carbon; hydrogen; sodium hydride; potassium carbonate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; HATU; In ethanol; 2,4-dichlorophenoxyacetic acid dimethylamine; ethyl acetate; N,N-dimethyl-formamide; mineral oil;
DOI:10.1016/j.tetlet.2012.05.025

Reference yield:

: 1384248-64-9
benzyl 2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)acetate

: 1384248-84-3
2-(5-cyclohexyl-3-methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[f][1,3,5]triazepin-1-yl)-N-(2-(dimethylamino)ethyl)acetamide

Guidance literature:: Multi-step reaction with 2 steps

1: palladium 10% on activated carbon; hydrogen / ethanol; ethyl acetate / 20 °C

2: dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; HATU / N,N-dimethyl-formamide / 20 °C

With dmap; palladium 10% on activated carbon; hydrogen; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; HATU; In ethanol; ethyl acetate; N,N-dimethyl-formamide;
DOI:10.1016/j.tetlet.2012.05.025